|
Jul 17
|
Bank of America Securities Reiterated a Buy Rating on Ultragenyx Pharmaceutical (RARE)
|
|
Jul 16
|
William Blair Maintains a Buy on Ultragenyx Pharmaceutical (RARE)
|
|
Jul 16
|
New Pedestrian Access from Inner Belt to East Somerville MBTA Station Now Open to the Public
|
|
Jul 15
|
Health Canada extends Evkeeza approval for children with HoFH
|
|
Jul 14
|
Ultragenyx Pharma Takes Another Hit As FDA Slaps Its Gene Therapy With A Rejection
|
|
Jul 14
|
Traders Digest Tariff Announcements, Driving Premarket Losses for US Equity Futures
|
|
Jul 14
|
Health Canada Extends the Approval of Evkeeza® (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)
|
|
Jul 14
|
FDA rejects Ultragenyx gene therapy over manufacturing concerns
|
|
Jul 14
|
Ultragenyx receives complete response letter for UX111 BLA
|
|
Jul 13
|
Ultragenyx (RARE) Falls 26% as New Treatment Fails to Get FDA Green Light
|
|
Jul 11
|
Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
|
|
Jul 11
|
Jazz names new CEO; Ultragenyx, Mereo shares slide on trial update
|
|
Jul 10
|
Ultragenyx, Mereo Hammered For Their Surprise Miss In Brittle Bone Disease
|
|
Jul 10
|
Sector Update: Health Care Stocks Rise Late Afternoon
|
|
Jul 10
|
Top Midday Decliners
|
|
Jul 10
|
Biotech Stock Ultragenyx Is Falling on Unsatisfying Trial Update
|
|
Jul 10
|
RARE, MREO Fall as Osteogenesis Study Likely to Continue Till Year End
|
|
Jul 10
|
Sector Update: Health Care Stocks Mixed Premarket Thursday
|
|
Jul 10
|
Ultragenyx (RARE) Surges 5.1%: Is This an Indication of Further Gains?
|
|
Jun 27
|
Ultragenyx Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome
|